Clinical studies recruiting near Greensboro

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
NA · Cone Health · Analog Device, Inc. · NCT05650541 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation Dur
Phase 2 · 3203, Greensboro CRS · National Institute of Allergy and Infectious Diseases (NIAID · NCT05719441 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Regional Center for Infectious Diseases ( Site 1516) · Merck Sharp & Dohme LLC · NCT07266831 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Guilford Neurologic Research Partners, LLC · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Novant Health Breast Surgery - Greensboro · NRG Oncology · NCT05624996 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Moses H Cone Memorial Hospital · Amgen · NCT07037433 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Regional Center for Infectious Diseases ( Site 0018) · Merck Sharp & Dohme LLC · NCT07044297 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Carolina Kidney Associates · Boehringer Ingelheim · NCT06531824 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · PharmQuest · Eli Lilly and Company · NCT05986292 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Carolina Kidney Associates · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Cone Health Cancer Center · NRG Oncology · NCT05174169 AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Phase N/A · Moses H. Cone Memorial Hospital · Peerbridge Health, Inc · NCT06699056 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Novant Health Breast Surgery - Greensboro · Alliance for Clinical Trials in Oncology · NCT06876714 A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults a
Phase 3 · GSK Investigational Site · ViiV Healthcare · NCT07650916 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · Cone Health Cancer Center · Canadian Cancer Trials Group · NCT03550391 Prevail Global Study
NA · The Moses H Cone Memorial Hospital · Medtronic Vascular · NCT06535854 E-Mindfulness Approaches for Living After Breast Cancer
Phase 3 · Cone Health Cancer Center · NRG Oncology · NCT06748222 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participant
Phase 2 · Medication Management · Eli Lilly and Company · NCT07589608 Inspiring Seniors Towards Exercise Promotion to Protect Cognition
NA · UNC Greensboro · Emory University · NCT06496425 Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · Adverum Clinical Site 211 · Adverum Biotechnologies, Inc. · NCT07482176 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Triad Clinical Trials · Crystalys Therapeutics · NCT07089888 A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Triad Clinical Trials · Uniquity One (UNI) · NCT06496620 WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Phase 2 · WISPer site in Greensboro, NC · Mediar Therapeutics · NCT06967805 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Site US10031 · Astellas Pharma Global Development, Inc. · NCT02960022 An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerabilit
Phase 3 · Medication Management LLC · Novartis Pharmaceuticals · NCT07517263 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Local Institution - 1221 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigational site 9809 · Anthos Therapeutics, Inc. · NCT05712200 Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
Phase 3 · Clinical Research Site 3 · Arrowhead Pharmaceuticals · NCT06880770 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · PharmQuest Life Sciences, LLC · Eli Lilly and Company · NCT07282600

Look up another city

Look up another condition